Other OTC - Delayed Quote USD

Premier Biomedical, Inc. (BIEI)

0.0017 +0.0002 (+13.33%)
At close: 3:05 PM EDT
Loading Chart for BIEI
DELL
  • Previous Close 0.0015
  • Open 0.0016
  • Bid --
  • Ask --
  • Day's Range 0.0016 - 0.0017
  • 52 Week Range 0.0005 - 0.0017
  • Volume 139,844
  • Avg. Volume 1,654,424
  • Market Cap (intraday) 1.813M
  • Beta (5Y Monthly) -4.13
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

www.premierbiomedical.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIEI

Performance Overview: BIEI

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIEI
88.89%
S&P 500
11.29%

1-Year Return

BIEI
240.00%
S&P 500
28.71%

3-Year Return

BIEI
29.17%
S&P 500
27.18%

5-Year Return

BIEI
92.48%
S&P 500
87.28%

Compare To: BIEI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIEI

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -153.58%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    14.28k

  • Net Income Avi to Common (ttm)

    -374.47k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    71.2k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -310.46k

Research Analysis: BIEI

Company Insights: BIEI

Research Reports: BIEI

People Also Watch